Grifols enters into agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada

7 September 2022 - The country, with an increasing immunoglobulin usage rate, currently imports about 85% of its immunoglobulin demand for ...

Read more →

Novo Nordisk expands product offerings in Canada for the treatment of haemophilia A in both children and adults, with availability of Esperoct and Zonovate

1 April 2022 - Newly available treatments can help Canadians living with haemophilia A better manage their bleeding episodes ...

Read more →

Campaign launched for life-sustaining treatment access across Canada

31 May 2021 - Alpha-1 Canada publicly launched Access for Alphas today, a campaign aimed at raising the awareness of alfa-1 ...

Read more →

Antihaemophilic factor (recombinant BDD) Fc fusion protein (Eloctate): treatment cost comparison and budget impact analysis

9 November 2015 - CADTH's final science report is now available for the project on antihaemophilic factor (recombinant BDD) Fc fusion ...

Read more →

Coagulation factor IX FC fusion protein (Alprolix): treatment cost comparison and budget impact analysis

9 November 2015 - CADTH's final science report is now available for the project on coagulation factor IX FC fusion protein ...

Read more →